Sign in

CIK 0001509745 · Non-accelerated filer<br>Smaller reporting company

CYPHERPUNK TECHNOLOGIES INC.

Sign in to watch
Ticker
CYPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
274412575
Phone
617 252 4343
Business address
47 THORNDIKE STREET, SUITE B1-1, CAMBRIDGE, MA, 02142
Former names
LEAP THERAPEUTICS, INC., Dekkun Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$888,900
in 3 filings

Net −$888,900. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Oei Khing Djien −$662K Director sold 100% of stake
  2. Martin Patricia A. −$193K Director sold 30% of stake
  3. Dietz Thomas John −$34K Director sold 13% of stake
Date Insider Transaction Shares Price Value Owned after
2022-09-01 O'Mahony John Mark Chief Manufacturing Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2022-09-01 Sirard Cynthia Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2022-09-01 LAWLOR AUGUSTINE Chief Operating Officer Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2022-09-01 Mirabelli Christopher Director Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2022-09-01 ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.,&Sec. Grant or award · Employee Stock Option (Right to Buy) +200,000 200,000
2022-09-01 Dietz Thomas John Director Grant or award · Stock Option (Right to Buy) +30,000 30,000
2022-09-01 LI WILLIAM Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-09-01 LOSCALZO JOSEPH Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-09-01 Mashiach Nissim Director Grant or award · Stock Option (Right to Buy) +25,000 25,000
2022-01-31 CAVANAUGH JAMES H Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2022-01-31 O'Mahony John Mark Chief Manufacturing Officer Grant or award · Restricted Stock Units +225,000 225,000
2022-01-31 Mashiach Nissim Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2022-01-31 Sirard Cynthia Chief Medical Officer Grant or award · Restricted Stock Units +225,000 225,000
2022-01-31 LOSCALZO JOSEPH Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2022-01-31 LAWLOR AUGUSTINE Chief Operating Officer Grant or award · Restricted Stock Units +225,000 225,000
2022-01-31 LI WILLIAM Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2022-01-31 Mirabelli Christopher Director Grant or award · Restricted Stock Units +225,000 225,000
2022-01-31 Dietz Thomas John Director Grant or award · Stock Option (Right to Buy) +60,000 60,000
2022-01-31 Bertagnolli Monica Director Grant or award · Stock Option (Right to Buy) +55,000 55,000
2022-01-31 ONSI DOUGLAS E CEO,CFO,Pres.,GC,Treas.,&Sec. Grant or award · Restricted Stock Units +325,000 325,000

Page 11 of 18 · 348 trades